vs
ARTIVION, INC.（AORT）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是ARTIVION, INC.的1.0倍（$117.7M vs $116.0M），ARTIVION, INC.净利率更高（2.1% vs -10.8%，领先12.8%），ARTIVION, INC.同比增速更快（19.2% vs -19.2%），RESOURCES CONNECTION, INC.自由现金流更多（$15.6M vs $-7.9M），过去两年ARTIVION, INC.的营收复合增速更高（9.1% vs -11.8%）
Artivion, Inc.是一家专注于心血管移植领域的医疗企业，主要供应经深低温冷冻保存的人体组织，同时研发各类医疗器械。旗下核心产品包括经过特殊处理、去除多余细胞物质与抗原的人体心脏瓣膜，以及BioGlue手术粘合剂，可为临床诊疗提供专业支持。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
AORT vs RGP — 直观对比
营收规模更大
RGP
是对方的1.0倍
$116.0M
营收增速更快
AORT
高出38.4%
-19.2%
净利率更高
AORT
高出12.8%
-10.8%
自由现金流更多
RGP
多$23.5M
$-7.9M
两年增速更快
AORT
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $116.0M | $117.7M |
| 净利润 | $2.4M | $-12.7M |
| 毛利率 | 63.1% | 37.1% |
| 营业利润率 | 9.2% | -10.3% |
| 净利率 | 2.1% | -10.8% |
| 营收同比 | 19.2% | -19.2% |
| 净利润同比 | 114.7% | 81.6% |
| 每股收益（稀释后） | $0.06 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AORTRGP
| Q4 25 | $116.0M | $117.7M | ||
| Q3 25 | $113.4M | $120.2M | ||
| Q2 25 | $113.0M | $139.3M | ||
| Q1 25 | $99.0M | $129.4M | ||
| Q4 24 | $97.3M | $145.6M | ||
| Q3 24 | $95.8M | $136.9M | ||
| Q2 24 | $98.0M | $148.2M | ||
| Q1 24 | $97.4M | $151.3M |
净利润AORTRGP
| Q4 25 | $2.4M | $-12.7M | ||
| Q3 25 | $6.5M | $-2.4M | ||
| Q2 25 | $1.3M | $-73.3M | ||
| Q1 25 | $-505.0K | $-44.1M | ||
| Q4 24 | $-16.5M | $-68.7M | ||
| Q3 24 | $-2.3M | $-5.7M | ||
| Q2 24 | $-2.1M | $10.5M | ||
| Q1 24 | $7.5M | $2.5M |
毛利率AORTRGP
| Q4 25 | 63.1% | 37.1% | ||
| Q3 25 | 65.6% | 39.5% | ||
| Q2 25 | 64.7% | 40.2% | ||
| Q1 25 | 64.2% | 35.1% | ||
| Q4 24 | 63.2% | 38.5% | ||
| Q3 24 | 63.7% | 36.5% | ||
| Q2 24 | 64.6% | 40.2% | ||
| Q1 24 | 64.6% | 37.0% |
营业利润率AORTRGP
| Q4 25 | 9.2% | -10.3% | ||
| Q3 25 | 11.1% | -1.7% | ||
| Q2 25 | 7.4% | -47.0% | ||
| Q1 25 | 2.2% | -38.4% | ||
| Q4 24 | 2.7% | -52.7% | ||
| Q3 24 | 4.6% | -3.5% | ||
| Q2 24 | 6.6% | 7.6% | ||
| Q1 24 | 26.0% | 2.8% |
净利率AORTRGP
| Q4 25 | 2.1% | -10.8% | ||
| Q3 25 | 5.7% | -2.0% | ||
| Q2 25 | 1.2% | -52.6% | ||
| Q1 25 | -0.5% | -34.0% | ||
| Q4 24 | -16.9% | -47.2% | ||
| Q3 24 | -2.4% | -4.2% | ||
| Q2 24 | -2.2% | 7.1% | ||
| Q1 24 | 7.7% | 1.7% |
每股收益（稀释后）AORTRGP
| Q4 25 | $0.06 | $-0.38 | ||
| Q3 25 | $0.13 | $-0.07 | ||
| Q2 25 | $0.03 | $-2.21 | ||
| Q1 25 | $-0.01 | $-1.34 | ||
| Q4 24 | $-0.40 | $-2.08 | ||
| Q3 24 | $-0.05 | $-0.17 | ||
| Q2 24 | $-0.05 | $0.31 | ||
| Q1 24 | $0.18 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.9M | $89.8M |
| 总债务越低越好 | $215.1M | — |
| 股东权益账面价值 | $448.2M | $194.6M |
| 总资产 | $884.8M | $289.3M |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势，按日历期对齐
现金及短期投资AORTRGP
| Q4 25 | $64.9M | $89.8M | ||
| Q3 25 | $73.4M | $77.5M | ||
| Q2 25 | $53.5M | $86.1M | ||
| Q1 25 | $37.7M | $72.5M | ||
| Q4 24 | $53.5M | $78.2M | ||
| Q3 24 | $56.2M | $89.6M | ||
| Q2 24 | $55.0M | $108.9M | ||
| Q1 24 | $51.1M | $113.8M |
总债务AORTRGP
| Q4 25 | $215.1M | — | ||
| Q3 25 | $214.9M | — | ||
| Q2 25 | $215.6M | — | ||
| Q1 25 | $314.7M | — | ||
| Q4 24 | $314.3M | — | ||
| Q3 24 | $314.0M | — | ||
| Q2 24 | $313.6M | — | ||
| Q1 24 | $313.3M | — |
股东权益AORTRGP
| Q4 25 | $448.2M | $194.6M | ||
| Q3 25 | $438.7M | $206.4M | ||
| Q2 25 | $419.9M | $207.1M | ||
| Q1 25 | $294.3M | $277.8M | ||
| Q4 24 | $276.2M | $325.7M | ||
| Q3 24 | $304.7M | $407.2M | ||
| Q2 24 | $295.1M | $418.8M | ||
| Q1 24 | $295.0M | $414.9M |
总资产AORTRGP
| Q4 25 | $884.8M | $289.3M | ||
| Q3 25 | $857.7M | $287.2M | ||
| Q2 25 | $838.4M | $304.7M | ||
| Q1 25 | $791.2M | $375.6M | ||
| Q4 24 | $789.1M | $424.9M | ||
| Q3 24 | $803.1M | $512.9M | ||
| Q2 24 | $789.5M | $510.9M | ||
| Q1 24 | $784.0M | $523.2M |
负债/权益比AORTRGP
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.49× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 1.06× | — | ||
| Q1 24 | 1.06× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.6M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $-7.9M | $15.6M |
| 自由现金流率自由现金流/营收 | -6.9% | 13.2% |
| 资本支出强度资本支出/营收 | 23.7% | 0.3% |
| 现金转化率经营现金流/净利润 | 8.06× | — |
| 过去12个月自由现金流最近4个季度 | $839.0K | $24.3M |
8季度趋势，按日历期对齐
经营现金流AORTRGP
| Q4 25 | $19.6M | $15.9M | ||
| Q3 25 | $22.3M | $-7.8M | ||
| Q2 25 | $15.0M | $16.8M | ||
| Q1 25 | $-17.0M | $659.0K | ||
| Q4 24 | $10.1M | $1.8M | ||
| Q3 24 | $11.5M | $-309.0K | ||
| Q2 24 | $6.1M | $3.2M | ||
| Q1 24 | $-5.5M | $20.5M |
自由现金流AORTRGP
| Q4 25 | $-7.9M | $15.6M | ||
| Q3 25 | $17.7M | $-8.0M | ||
| Q2 25 | $11.7M | $16.5M | ||
| Q1 25 | $-20.6M | $238.0K | ||
| Q4 24 | $8.7M | $61.0K | ||
| Q3 24 | $7.8M | $-575.0K | ||
| Q2 24 | $3.6M | $3.0M | ||
| Q1 24 | $-9.1M | $20.4M |
自由现金流率AORTRGP
| Q4 25 | -6.9% | 13.2% | ||
| Q3 25 | 15.6% | -6.6% | ||
| Q2 25 | 10.4% | 11.8% | ||
| Q1 25 | -20.8% | 0.2% | ||
| Q4 24 | 9.0% | 0.0% | ||
| Q3 24 | 8.2% | -0.4% | ||
| Q2 24 | 3.7% | 2.1% | ||
| Q1 24 | -9.3% | 13.5% |
资本支出强度AORTRGP
| Q4 25 | 23.7% | 0.3% | ||
| Q3 25 | 4.1% | 0.1% | ||
| Q2 25 | 2.9% | 0.2% | ||
| Q1 25 | 3.7% | 0.3% | ||
| Q4 24 | 1.5% | 1.2% | ||
| Q3 24 | 3.8% | 0.2% | ||
| Q2 24 | 2.6% | 0.1% | ||
| Q1 24 | 3.7% | 0.1% |
现金转化率AORTRGP
| Q4 25 | 8.06× | — | ||
| Q3 25 | 3.42× | — | ||
| Q2 25 | 11.16× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | -0.73× | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AORT
| Aortic Stent Grafts | $43.3M | 37% |
| On X | $27.8M | 24% |
| Preservation Services | $24.1M | 21% |
| Surgical Sealants | $20.3M | 18% |
| Other Products | $463.0K | 0% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
